A Combined Human in Silico and CRISPR/Cas9-Mediated in Vivo Zebrafish Based Approach to Provide Phenotypic Data for Supporting Early Target Validation. (2022)
Attributed to:
Quantitative analysis of cytoneme-based Wnt trafficking and signalling in vivo
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3389/fphar.2022.827686
PubMed Identifier: 35548346
Publication URI: http://europepmc.org/abstract/MED/35548346
Type: Journal Article/Review
Volume: 13
Parent Publication: Frontiers in pharmacology
ISSN: 1663-9812